格灵深瞳(688207) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥30,726,615.23, representing a decrease of 54.51% compared to the same period last year[5] - The net profit attributable to shareholders was a loss of ¥27,099,447.96, with a net profit excluding non-recurring gains and losses of ¥29,442,358.34, both figures not applicable for percentage change[5] - The net loss for Q1 2024 was ¥27,186,116.94, compared to a net loss of ¥908,120.50 in Q1 2023, indicating a significant increase in losses[22] - Basic and diluted earnings per share for Q1 2024 were both -¥0.10, compared to ¥0 in Q1 2023[23] - Total operating revenue for Q1 2024 was ¥30,726,615.23, a decrease of 54.5% compared to ¥67,543,770.98 in Q1 2023[21] - Total operating costs for Q1 2024 were ¥62,459,063.59, down from ¥69,566,115.11 in Q1 2023, representing a decrease of 10.1%[21] Cash Flow - The net cash flow from operating activities was a negative ¥31,126,903.67, showing an increase in outflow by 22.48% year-on-year[5] - In Q1 2024, the net cash flow from operating activities was -31,126,903.67, an improvement from -40,151,183.78 in Q1 2023, indicating a reduction in cash outflow[25] - The total cash outflow from operating activities in Q1 2024 was 79,123,664.27, down from 107,309,061.78 in Q1 2023, indicating improved operational efficiency[25] - Cash received from other operating activities in Q1 2024 was 16,481,579.39, up from 7,430,102.70 in Q1 2023, indicating increased operational revenue streams[25] - The cash flow from financing activities in Q1 2024 was -5,658,183.56, an increase in outflow compared to -1,707,403.10 in Q1 2023, suggesting higher financing costs or repayments[25] Research and Development - Research and development (R&D) expenses totaled ¥44,240,652.27, which is an increase of 31.90% compared to the previous year[6] - R&D expenses accounted for 143.98% of operating revenue, an increase of 94.91 percentage points year-on-year[6] - R&D expenses increased to ¥44,240,652.27 in Q1 2024, up 33.4% from ¥33,143,232.46 in Q1 2023[21] - The company plans to continue increasing its R&D investment despite the decrease in revenue, indicating a focus on long-term growth strategies[9] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,429,248,193.25, a decrease of 1.74% from the end of the previous year[6] - Total assets decreased to ¥2,429,248,193.25 in Q1 2024 from ¥2,472,307,952.09 in Q1 2023, a decline of 1.7%[19] - Total liabilities decreased to ¥169,198,407.93 in Q1 2024 from ¥187,261,415.53 in Q1 2023, a reduction of 9.6%[19] - The company’s total equity decreased to ¥2,260,049,785.32 in Q1 2024 from ¥2,285,046,536.56 in Q1 2023, a decline of 1.1%[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,165[11] - The largest shareholder, Tianjin Deep Vision Technology Center, holds 43,765,884 shares, accounting for 16.90% of total shares[11] - The company has a total of 16,133,846 unrestricted shares held by HSG CV IV Holdco IX, Ltd.[12] - The number of shares lent out for margin trading by Haitong Innovation Securities increased to 2,127,119, representing 0.82% of total shares[13] Market Environment - The decline in operating revenue was attributed to delayed contract renewals from some clients and a downturn in the market environment affecting certain industries[9] Investment Performance - Total cash inflow from investment activities in Q1 2024 was 1,342,025,151.14, significantly higher than 81,331,566.11 in Q1 2023, driven by a substantial increase in cash recovered from investments[25] - The net cash flow from investment activities in Q1 2024 was 262,900,335.11, a positive turnaround from -448,193,588.79 in Q1 2023, reflecting improved investment performance[25] - Cash received from the recovery of investments in Q1 2024 reached 1,339,210,000.00, compared to only 81,120,000.00 in the same period last year, highlighting a significant growth in investment recovery[25]